Zobrazeno 1 - 10
of 42
pro vyhledávání: '"R A, Stahel"'
Autor:
R.-A. Stahel
Publikováno v:
Revue de Pneumologie Clinique. 62:15-19
Autor:
R-A, Stahel
Publikováno v:
Revue de pneumologie clinique. 62(6 Pt 2)
Autor:
R. A. Stahel
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 16
Autor:
L. M. Jost, R. A. Stahel
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 16
Publikováno v:
British Journal of Cancer
The biodistribution of radiolabelled SWA11, a mouse monoclonal antibody recognising the cluster w4 group antigen associated with small cell lung cancer (SCLC) was studied in patients with SCLC. Five patients were injected intravenously with approxima
Publikováno v:
British journal of haematology. 114(2)
Persistent polyclonal B-cell lymphocytosis (PPBL) is a rare disorder of unknown aetiology affecting predominantly young to middle-aged women. It is characterized by a polyclonal expansion of B cells, including typical binucleated lymphocytes, and is
Autor:
G, Pichert, R A, Stahel
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 18
Inherited predisposition to cancer is a complex issue, and risk assessment, counseling, and management are multidisciplinary tasks. An infrastructure is needed through which clinical services may be delivered and research activities conducted.The Swi
Publikováno v:
Oncology. 59(2)
The prognosis of germ cell tumors treated with chemotherapy depends on the presence of nonseminomatous tumor, clinical parameters based on the tumor volume and site, as well as on the level of the tumor markers AFP, betaHCG and LDH. We report here on
Autor:
A P, Simões-Wüst, R A, Olie, O, Gautschi, S H, Leech, R, Häner, J, Hall, D, Fabbro, R A, Stahel, U, Zangemeister-Wittke
Publikováno v:
International journal of cancer. 87(4)
Upregulated expression of bcl-xL is involved in the initiation and progression of breast cancer by inhibiting tumor cell apoptosis. Here we describe the use of the 2;-O-methoxy-ethoxy antisense oligonucleotide 4259 targeting nucleotides 687-706 of th
Autor:
U, Zangemeister-Wittke, S H, Leech, R A, Olie, A P, Simões-Wüst, O, Gautschi, G H, Luedke, F, Natt, R, Häner, P, Martin, J, Hall, C M, Nalin, R A, Stahel
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(6)
Bcl-2 and Bcl-xL are inhibitors of apoptosis frequently overexpressed in solid tumors. The bcl-2 and bcl-xL mRNAs share a region of homology comprising nucleotides 605-624 and 687-706, respectively, which differs by only three nucleotides. This seque